Mylan Pharmaceuticals Inc. recalls Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays,
Recalled February 13, 2019 · FDA recall D-0424-2019 · Mylan Pharmaceuticals
Hazard
Defective Container: Potential for broken glass in the neck area of the glass bottles. · FDA Class II
Units
10,390 bottles
Sold at
Nationwide in the USA.
Description
Defective Container: Potential for broken glass in the neck area of the glass bottles.
Product
Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: Meda Pharmaceuticals Inc., Somerset, New Jersey 08873-4120, NDC 0037-0245-23.
Manufacturer(s)
Mylan Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →